IRulya Therapeutics Names Brigette Roberts CEO

PUBT · 1d ago
IRulya Therapeutics Names Brigette Roberts CEO
  • IRulya Therapeutics appointed Brigette Roberts, M.D., chief executive officer.
  • John Militello, CPA, became chief financial officer; Keith Fandrick, Ph.D., was named chief operating officer.
  • Catherine Bonuccelli, M.D., and Leone Patterson joined the board.
  • Other new directors include James Valentine, J.D., M.H.S., and Drayton Wise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRulya Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611130800PRIMZONEFULLFEED9877051) on November 13, 2026, and is solely responsible for the information contained therein.